ETF Comparison: XUHC vs LYPE
ETFã®èª¬æ
XUHC - Xtrackers MSCI USA Health Care UCITS ETF 1D
The Xtrackers MSCI USA Health Care UCITS ETF 1D is an equity fund that tracks the MSCI USA Health Care index, providing exposure to large and medium-sized US healthcare companies. With a low expense ratio of 0.12%, the fund distributes dividends annually and has a long-only investment strategy.
LYPE - Amundi MSCI World Health Care UCITS ETF EUR Acc
The Amundi MSCI World Health Care UCITS ETF EUR Acc is an exchange-traded fund that tracks the MSCI World Health Care index, providing exposure to the health care sector of developed markets worldwide. The fund uses a synthetic replication method with a swap and accumulates dividends, reinvesting them in the ETF.
æ¯èŒããŒãã«
| XUHC | LYPE | |
|---|---|---|
| ãã¡ã³ãå | Xtrackers MSCI USA Health Care UCITS ETF 1D | Amundi MSCI World Health Care UCITS ETF EUR Acc |
| Fund Provider | Deutsche Bank | Amundi |
| Index | MSCI USA Health Care | MSCI World Health Care |
| Asset Class | Equity | Equity |
| Listing | EU-listed | EU-listed |
| Expense Ratio | 0.12% | 0.3% |
| Inception Date | 2017-09-12 | 2010-08-19 |
| Currency | USD | EUR |
| Distribution Policy | Distributing | Accumulating |
| Region | United States | Global |
| Investment Style | Blend | Blend |
| Market Cap | Large-Cap | Blend |
| Sector | Healthcare | Healthcare |
| Sector Detail | Health Care | Health Care |
| Leveraged | Non-leveraged | Non-leveraged |
ããã¯ãã¹ããªãã·ã§ã³
ãµããªãŒ
äž»èŠææš
ããã©ãŒãã³ã¹ææš
ãªã¹ã¯ææš
詳现ãªã¿ãŒã³
ããã©ãŒãã³ã¹åæ
ããã©ãŒãã³ã¹åæã¯ã环ç©ãªã¿ãŒã³ã幎æ«ïŒEoYïŒãªã¿ãŒã³ãSharpeã¬ã·ãªãSortinoã¬ã·ãªãªã©ã®ãªã¹ã¯èª¿æŽæžã¿ææšãéããŠãæè³æŠç¥ã®ãªã¿ãŒã³ãè©äŸ¡ããããã«éå»ããŒã¿ãè©äŸ¡ããŸããããã«ãããæè³å®¶ã¯ããŸããŸãªåžå Žç°å¢ã§ã®çµ¶å¯Ÿçããã³çžå¯Ÿçãªããã©ãŒãã³ã¹ãè©äŸ¡ã§ããŸãã
环ç©ãªã¿ãŒã³
幎æ«ãªã¿ãŒã³ããŒãã«
幎æ«ãªã¿ãŒã³
ãªã¹ã¯åæ
ãªã¹ã¯åæãšã¯ãè³æ¬ã®æå€±ã«ã€ãªããå¯èœæ§ã®ããæœåšçãªãã¬ãã£ãã€ãã³ãã®è©äŸ¡ãæããŸãããªã¹ã¯åæã宿œããããšã§ãæè³ãè¡ãã¹ããã©ããã®å€æã«åœ¹ç«ãŠãããšãã§ããŸããããã¯ãæè³æŠç¥ã®äžè²«æ§ã«å¯Ÿããå©å®³é¢ä¿è ã®ä¿¡é Œãåæ ãããããŒããŠã³ããã©ãã£ãªãã£ãããŒã¿ãªã©ã®ãªã¹ã¯ææšã䜿çšããŠè¡ãããŸãã
ãããŒããŠã³
ãããŒããŠã³ããŒãã«
ã¢ã³ãã«ã«ãã·ãã¥ã¬ãŒã·ã§ã³
ã¢ã³ãã«ã«ãã·ãã¥ã¬ãŒã·ã§ã³ã¯ãéå»ã®è³ç£äŸ¡æ ŒããŒã¿ããã®ã©ã³ãã ãµã³ããªã³ã°ãéããŠå¹ åºãæœåšçãªçµæãçæããããšã§ãããŒããã©ãªãªã®ãªã¿ãŒã³ãäºæž¬ããããã«äœ¿çšãããçµ±èšçææ³ã§ããããŸããŸãªåžå Žæ¡ä»¶äžã§ã®ããŒããã©ãªãªã®æœåšçãªãªã¹ã¯ãšãªã¿ãŒã³ãè©äŸ¡ããã®ã«åœ¹ç«ã¡ãŸãããã®ã·ãã¥ã¬ãŒã·ã§ã³ã¯åææè³ãèæ ®ããå®é¡ç©ç«ãå®é¡åŒãåºããå²ååŒãåºããªã©ã®ãã£ãã·ã¥ãããŒã·ããªãªããªãã·ã§ã³ã§ã·ãã¥ã¬ãŒãããŸãã
éèŠïŒã¢ã³ãã«ã«ãã·ãã¥ã¬ãŒã·ã§ã³ã«ãã£ãŠçæãããäºæž¬ã¯çŽç²ã«ä»®èª¬çãªãã®ã§ãããå°æ¥ã®ãªã¿ãŒã³ãä¿èšŒãããã®ã§ã¯ãããŸãããæè³å€æã¯ããŸããŸãªèŠå ãèæ ®ããäžã§è¡ãã¹ãã§ãããéå»ã®ããã©ãŒãã³ã¹ã¯å°æ¥ã®çµæã瀺ããã®ã§ã¯ãããŸããã